UBS reiterated a Buy rating and $148.00 price target on Medivation (NASDAQ: MDVN) as shares continue to fall. Shares are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE